Multiple Sclerosis Research Today is a free monthly online journal that collates and summarizes the latest research about Multiple Sclerosis, including details on diagnosis, symptoms, treatment, prognosis.

Volume 3 (2006), Issue 2 (February)

1. Cancer risk among patients with multiple sclerosis: a population-based register study.
   Int J Cancer, 118(4): 979-84. [Abstract] [Full-text]
2. Multifocal visual evoked potential analysis of inflammatory or demyelinating optic neuritis.
   Ophthalmology, 113(2): 323.e1-323.e2. [Abstract] [Full-text]
3. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis.
   Ophthalmology, 113(2): 324-32. [Abstract] [Full-text]
4. Age at disability milestones in multiple sclerosis.
   Brain, 129: 595-605. [Abstract] [Full-text]
5. Natural history of multiple sclerosis: a unifying concept.
   Brain, 129: 606-16. [Abstract] [Full-text]
6. The natural history of multiple sclerosis: a geographically based study 9: observations on the progressive phase of the disease.
   Brain, 129: 584-94. [Abstract] [Full-text]
7. Risk of multiple sclerosis after head injury: record linkage study.
   J Neurol Neurosurg Psychiatry, 77(3): 351-3. [Abstract] [Full-text]
8. Quantification of central motor conduction deficits in multiple sclerosis patients before and after treatment of acute exacerbation by methylprednisolone.
   J Neurol Neurosurg Psychiatry, 77(3): 345-50. [Abstract] [Full-text]
9. Clinically isolated syndromes: a new oligoclonal band test accurately predicts conversion to MS.
   Neurology, 66(4): 576-8. [Abstract] [Full-text]
10. Allergy, histamine 1 receptor blockers, and the risk of multiple sclerosis.
    Neurology, 66(4): 572-5. [Abstract] [Full-text]
11. Relationship between inflammatory lesions and cerebral atrophy in multiple sclerosis.
    Neurology, 66(4): 551-6. [Abstract] [Full-text]
12. Safety and tolerability of interferon beta-1b in pediatric multiple sclerosis.
    Neurology, 66(4): 472-6. [Abstract] [Full-text]
13. The cardiac effects of mitoxantrone: do the benefits in multiple sclerosis outweigh the risks?
    Expert Opin Drug Saf, 5(2): 265-74. [Abstract] [Full-text]

© 2004-2008 Multiple Sclerosis Research Today. All Rights Reserved.